Loading clinical trials...
Loading clinical trials...
PreOperative Treatment With chEmotheRapy or chemoRAdiatioN in esophaGeal or gastroEsophageal adenocaRcinoma
Conditions
Interventions
(Epirubicin Cisplatin 5-Fluorouracil / Xeloda) OR 5-Fluorouracil Leucovorin Oxaliplatin Docetaxel
Carboplatin paclitaxel plus concurrent radiotherapy
Locations
3
Canada
Health Sciences Centre / CancerCare Manitoba
Winnipeg, Manitoba, Canada
London Health Sciences Centre
London, Ontario, Canada
Toronto General Hospital / Princess Margaret Hospital
Toronto, Ontario, Canada
Start Date
September 1, 2015
Primary Completion Date
August 1, 2023
Completion Date
August 1, 2023
Last Updated
August 28, 2024
NCT06713993
NCT06257264
NCT00242723
NCT05005403
NCT06253871
NCT04674267
Lead Sponsor
Dr. Gordon Buduhan
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions